AGP Picks
View all

Falkland Islands Science Times
Provided by AGP

Falkland Islands Science Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Falkland Islands Science Times.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on August 17, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET
Aug. 17, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET

Indeterminate GlobeNewswire
EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU™ 2.7mg in Wet AMD
Aug. 17, 2026

EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU™ 2.7mg in Wet AMD

Indeterminate GlobeNewswire
Enovix Announces CEO Transition and Search
Aug. 17, 2026

Enovix Announces CEO Transition and Search

Indeterminate GlobeNewswire
Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic Cancer
Aug. 17, 2026

Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic Cancer

Indeterminate GlobeNewswire
BASECAT Announces Community Takeover: The Blue Hardhat Cat Building an Army on Base
Aug. 17, 2026

BASECAT Announces Community Takeover: The Blue Hardhat Cat Building an Army on Base

Indeterminate GlobeNewswire
Blue Ops, a Red Cat Company, and Havoc Partner to Develop Open-Architecture Autonomous Maritime Defense Systems
Aug. 17, 2026

Blue Ops, a Red Cat Company, and Havoc Partner to Develop Open-Architecture Autonomous Maritime Defense Systems

Indeterminate GlobeNewswire
Evolution Metals & Technologies Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug. 17, 2026

Evolution Metals & Technologies Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Somantra AI, an Enterprise-Grade AEO GEO and AI Search Visibility Platform, Publishes "Content Graveyard" Analysis: 57% of Domains Cited in ChatGPT and Google Are Never Cited Again
Aug. 17, 2026

Somantra AI, an Enterprise-Grade AEO GEO and AI Search Visibility Platform, Publishes "Content Graveyard" Analysis: 57% of Domains Cited in ChatGPT and Google Are Never Cited Again

Indeterminate GlobeNewswire
argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis
Aug. 17, 2026

argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis

Indeterminate GlobeNewswire
Instaleap baut seine Präsenz in Europa durch eine strategische Partnerschaft mit SPAR Slowenien aus
Aug. 17, 2026

Instaleap baut seine Präsenz in Europa durch eine strategische Partnerschaft mit SPAR Slowenien aus

Indeterminate GlobeNewswire
Instaleap renforce sa présence en Europe grâce à un partenariat stratégique avec SPAR Slovénie
Aug. 17, 2026

Instaleap renforce sa présence en Europe grâce à un partenariat stratégique avec SPAR Slovénie

Indeterminate GlobeNewswire
Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain
Aug. 17, 2026

Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain

Indeterminate GlobeNewswire
HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO®
Aug. 17, 2026

HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO®

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Falkland Islands Science Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.